The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Sep. 27, 2017
Applicant:
Genocea Biosciences, Inc., Cambridge, MA (US);
Inventor:
Seth Vollmer Hetherington, Chapel Hill, NC (US);
Assignee:
Genocea Biosciences, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/04 (2006.01); A61K 31/52 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61P 31/22 (2006.01); A61K 31/522 (2006.01); A61K 39/245 (2006.01); C07K 14/035 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
A61K 39/245 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 38/00 (2013.01); A61K 39/12 (2013.01); A61P 31/22 (2018.01); C07K 14/035 (2013.01); C12N 7/04 (2013.01); G01N 33/56994 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55577 (2013.01); C12N 2710/16622 (2013.01); C12N 2710/16634 (2013.01); G01N 2333/035 (2013.01);
Abstract
The present disclosure provides certain combinations of immunogenic compositions against HSV-2 and antiviral therapy. The vaccines can be used therapeutically and/or prophylactically.